Harboring the APOE4 allele enhances the risk for AD and several reports have suggested that the proteolytic cleavage of apoE4 into N- and C-terminal fragments may provide a mechanism by which this protein contributes to AD pathogenesis (for recent review, see [21]). This evidence concerns the gene APOE and Alzheimer disease.